Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ARXS | GD |
|---|---|---|
| Price | $48.41 | $332.85 |
| Change today | ▼ 1.98% | ▲ 0.31% |
| Market cap | $20.86B | $90.05B |
| Return, 3 months | +4.0% | -7.9% |
| Return, year to date | – | +0.2% |
| Return, 1 year | – | -0.6% |
| P/E (TTM) | 157.7 | 20.3 |
| P/B | 4.7 | 3.4 |
| P/E percentile vs own 5y | 19th | 62nd |
| Dividend yield | – | 1.86% |
| Revenue growth (YoY, latest qtr) | +25.0% | +8.1% |
| Net profit growth (YoY) | +83.2% | +14.4% |
| Gross margin | 50.3% | 15.4% |
| Operating margin | 6.1% | 10.3% |
| Net margin | 1.8% | 8.2% |
| Return on equity | 0.7% | 17.8% |
| Analyst target vs. price | +26.4% | +27.2% |
| Analyst buy share | 86% | 50% |
| RSI (14) | 43 | 26 |
| 30-day volatility | 34.1% | 18.6% |
| Max drawdown, 1 year | -19.3% | -16.1% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
